News | February 09, 2012

Stereotaxis Announces European Adoption Milestone and Health Canada Clearance for Vdrive

February 9, 2012 — Stereotaxis Inc. said its Vdrive robotic navigation system, which provides physicians the ability to remotely manipulate traditionally non-robotic catheters, is growing in popularity and is expected to surpass 500 clinical procedures in Europe in February.  The company also announced it has received regulatory clearance from Health Canada to commercially market the device in the country.

Since the initial product release in Europe in 2011, the Vdrive system has been installed in nine centers, with units to be installed in additional centers during the first quarter of 2012.  The initial nine have performed 473 clinical cases with approximately 80 percent being completed in the left atrium of the heart. 

Numerous cases have been performed with the Vdrive system and clinical feedback continues to be very positive," said Michael Kaminski, president and CEO of Stereotaxis.  "With the Health Canada market clearance for the Vdrive system, and our planned new Vdrive installations in Europe and Canada this year, we are well-positioned to drive the growth and further adoption of this exciting technology in electrophysiology labs in these important markets."

In a fully remote procedure environment, the Vdrive system increases the clinical techniques available to the physician and reduces the need to re-enter the sterile field to adjust devices.  Initial clinical data from European physicians demonstrates that this simplification saves 30 minutes or more in robotic procedures, depending on individual clinical technique.  Furthermore, the addition of robotic diagnostic catheter manipulation is another step to improve device control.  Stereotaxis' broad Epoch solutions portfolio also includes precise magnetic control of ablation catheters with Niobe ES and integrated display and control of multiple lab technologies with the Odyssey clinical information management system. 

The design of the Vdrive system allows the robotic hardware to adapt to different clinical techniques depending on the disposable adaptor that is attached to the arm:

  • V-Loop circular catheter manipulator allows control of circular diagnostic catheters, primarily in left atrial procedures.
  • V-CAS catheter advancement system allows advancement and retraction of the magnetic catheter as well as robotic manipulation of catheter introducer sheaths that are already in use during the procedure. 
  • V-CAS Deflect catheter advancement system is a more advanced device that includes an integrated robotic deflectable sheath.

Initial positive results from multiple physician users confirmed the significant clinical value delivered by the Vdrive system related to procedure efficiency. 

For more information: www.stereotaxis.com

Related Content

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Overlay Init